About: Matthias von Herrath

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Matthias von Herrath Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Attributes	Values
rdf:type	Item
description	forskare (sv) 연구원 (ko) 研究者 (ja) araştırmacı (tr) wetenschapper (nl) дослідник (uk) эрдэмтэн (mn) वैज्ञानिक (hi) изилдөөчү (ky) 研究者 (zh)
rdfs:label	Matthias von Herrath (en) Matthias von Herrath (fr) Matthias von Herrath (nl) Matthias von Herrath (ast)
skos:prefLabel	Matthias von Herrath (en) Matthias von Herrath (fr) Matthias von Herrath (nl) Matthias von Herrath (ast)
name	Matthias von Herrath (en) Matthias von Herrath (fr) Matthias von Herrath (nl) Matthias von Herrath (ast)
given name	wds:Q64532773-B5F3225C-1BC9-4DEE-805A-B80BCA465125
given name	Matthias
instance of	wds:Q64532773-66339554-4d25-f129-3934-79dcf5c82b4a
instance of	Homo sapiens
award received	wds:Q64532773-6F7630EB-9BC1-4FC8-B134-2AEED18A4026
award received	Paul Langerhans Medal
Nationale Thesaurus voor Auteursnamen ID	wds:Q64532773-b56517a9-d3ce-4ed2-b6d9-ddf8324cd688
occupation	wds:Q64532773-52DE76A6-95CA-42CA-B58F-218AC4FB8780
sex or gender	wds:Q64532773-f43e23d8-411f-6813-a5dc-307a6885a077
VIAF ID	wds:Q64532773-8fe442fb-4de6-b7b4-3106-f4439fe2505c
IdRef ID	wds:Q64532773-08d89e29-0b98-443a-b089-95031cf9b74f
WorldCat Identities ID (superseded)	wds:Q64532773-B5AE1529-355E-44A8-803C-A2AEC8AC32E2
National Library of Israel J9U ID	wds:Q64532773-201A0E7B-6573-4257-BD7C-0C94436B6819
Nationale Thesaurus voor Auteursnamen ID	http://data.bibliotheken.nl/id/thes/p238069818
VIAF ID	http://viaf.org/viaf/5113321
IdRef ID	http://www.idref.fr/061580961/id
Nationale Thesaurus voor Auteursnamen ID	238069818
occupation	researcher
sex or gender	male
VIAF ID	5113321
IdRef ID	061580961
WorldCat Identities ID (superseded)	lccn-n2001128479
National Library of Israel J9U ID	987007322413905171
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q64532773
is author of	TGF-β blockade does not improve control of an established persistent viral infection Type 1 diabetes as a relapsing-remitting disease? The clinical and immunological significance of GAD-specific autoantibody and T-cell responses in type 1 diabetes. Can we learn from viruses how to prevent type 1 diabetes?: the role of viral infections in the pathogenesis of type 1 diabetes and the development of novel combination therapies CD8 T-cell reactivity to islet antigens is unique to type 1 while CD4 T-cell reactivity exists in both type 1 and type 2 diabetes Islet antigen specific IL-10+ immune responses but not CD4+CD25+FoxP3+ cells at diagnosis predict glycemic control in type 1 diabetes Diabetes: A virus-gene collaboration How viral infections affect the autoimmune process leading to type 1 diabetes A novel technique for the in vivo imaging of autoimmune diabetes development in the pancreas by two-photon microscopy Remodeling rodent models to mimic human type 1 diabetes Antigen-driven effector CD8 T cell function regulated by T-bet Protection against or triggering of Type 1 diabetes? Different roles for viral infections NKT cell-plasmacytoid dendritic cell cooperation via OX40 controls viral infection in a tissue-specific manner. Viral infection prevents diabetes by inducing regulatory T cells through NKT cell-plasmacytoid dendritic cell interplay. Islet cell hyperexpression of HLA class I antigens: a defining feature in type 1 diabetes Opinion: Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes Antigen-specific immunotherapy for type 1 diabetes: maximizing the potential Anti-CD3 and nasal proinsulin combination therapy enhances remission from recent-onset autoimmune diabetes by inducing Tregs Molecular and cellular control of T1/T2 immunity at the interface between antimicrobial defense and immune pathology Immunosuppression in islet transplantation Immunotherapy for the prevention and treatment of type 1 diabetes: optimizing the path from bench to bedside Plasmid-encoded proinsulin preserves C-peptide while specifically reducing proinsulin-specific CD8⁺ T cells in type 1 diabetes Preexisting autoantibodies predict efficacy of oral insulin to cure autoimmune diabetes in combination with anti-CD3. Humanizing animal models: a key to autoimmune diabetes treatment Regulatory T cells and type 1 diabetes Inflammation and hyperglycemia mediate Deaf1 splicing in the pancreatic lymph nodes via distinct pathways during type 1 diabetes CTSH regulates β-cell function and disease progression in newly diagnosed type 1 diabetes patients Current concepts on the pathogenesis of type 1 diabetes--considerations for attempts to prevent and reverse the disease The microbiology of human hygiene and its impact on type 1 diabetes Interleukin-21 is required for the development of type 1 diabetes in NOD mice Antigen-specific induction of regulatory T cells for type 1 diabetes therapy Can an immune-regulatory vaccine prevent HIV infection? Antigen-specific prevention of type 1 diabetes in NOD mice is ameliorated by OX40 agonist treatment Intravital imaging of CTLs killing islet cells in diabetic mice Navigating diabetes-related immune epitope data: resources and tools provided by the Immune Epitope Database (IEDB) Combination therapies for type 1 diabetes: why not now? Exogenous OX40 stimulation during lymphocytic choriomeningitis virus infection impairs follicular Th cell differentiation and diverts CD4 T cells into the effector lineage by upregulating Blimp-1. Islet regeneration needed for overcoming autoimmune destruction - considerations on the pathogenesis of type 1 diabetes CD103 is dispensable for anti-viral immunity and autoimmunity in a mouse model of virally-induced autoimmune diabetes Limitations in immunotherapy with CD3 antibodies: comment on the article by Drs. Chatenoud and Bach 2011 Update: antigen-specific therapy in type 1 diabetes Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice Immunotherapy of type 1 diabetes--how to rationally prioritize combination therapies in T1D. Genetic-induced variations in the GAD65 T-cell repertoire governs efficacy of anti-CD3/GAD65 combination therapy in new-onset type 1 diabetes Virtual optimization of nasal insulin therapy predicts immunization frequency to be crucial for diabetes protection Different diabetogenic potential of autoaggressive CD8+ clones associated with IFN-gamma-inducible protein 10 (CXC chemokine ligand 10) production but not cytokine expression, cytolytic activity, or homing characteristics. Introducing baselines for therapeutic use of regulatory T cells and cytokines in autoimmunity. Enteroviruses, hygiene and type 1 diabetes: toward a preventive vaccine Following the fate of one insulin-reactive CD4 T cell: conversion into Teffs and Tregs in the periphery controls diabetes in NOD mice How can we improve the translational landscape for a faster cure of type 1 diabetes? Immunology: insulin trigger for diabetes. Direct infection of dendritic cells during chronic viral infection suppresses antiviral T cell proliferation and induces IL-10 expression in CD4 T cells Type 1 diabetes vaccine development: animal models vs. humans

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 183 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software